Efficacy of compound xuanju capsule on type-IIi prostatitis-related sexual dysfunction
Li, X.-d.; Shao, H.-L.; Song, G.-J.; Chang, Y.-H.; Li, X.-L.; Wang, L.-N.; Wang, L.; Wei, S.
Zhonghua Nan Ke Xue 18(7): 665-668
2012
ISSN/ISBN: 1009-3591 PMID: 22994055 Document Number: 663041
To investigate the value of Compound Xuanju Capsule in the treatment of type-III prostatitis-related sexual dysfunction. We randomly divided 90 type-III prostatitis patients with sexual dysfunction diagnosed by NIH clinical criteria into an experiment group and a control group to be treated with Compound Xuanju Capsule and antibiotics, respectively. We analyzed the therapeutic results based on the scores on chronic prostatitis symptom index (CPSI), prostatitis-related sexual function index (PSFI ) and self-rating anxiety scale (SAS), and compared them between the two groups and with the baseline data. The degree of prostatitis-related sexual dysfunction was not correlated with that of prostatitis symptoms. Prostatitis symptoms and sexual function were significantly improved in the experiment group than in the control (P < 0.05), and the SAS score was markedly lower in the former than in the latter (P < 0.05). Compound Xuanju Capsule can not only alleviate the symptoms of type-III prostatitis, but also improve its related sexual dysfunction and anxiety.